Genespire
  • About us
    • The company
    • Board of Directors
    • Founders
    • Investors
  • Our science
    • Inherited Metabolic Disorders
    • Primary Immunodeficiency Disorders
  • Our Programs
    • HIGM
  • News and Events
    • News
  • Contact
  • IT
  • EN
Select Page

News

Milan, July 30, 2020
Genespire appoints Jörn Aldag as Chairman of the Board of Directors

Milan, June 30, 2020
Genespire and the San Raffaele Telethon Institute for Gene Therapy announce publication in Nature Biotechnology on enhanced gene editing technique in hematopoietic stem cells

Milan, May 13, 2020
Genespire and SR-Tiget announce strategic alliance for the development of transformative gene therapies for genetic diseases and disclose collaboration focus

Milan, April 29, 2020
Genespire Secures €16 Million Series A Financing from Sofinnova Partners to Advance Transformative Gene Therapies

Genespire

Genespire’s mission is to bring transformative
gene therapies to people affected by genetic
diseases with high unmet medical need

Contact us

Via Vincenzo Gioberti, 8
20123 Milano
Italy

phone: +39 02 83991340
e-mail: info@genespire.com

Useful links

  • Privacy Policy
  • Cookie Policy
  • Credits
© 2020 GENESPIRE Srl. All rights reserved. VAT: 11231080968
This website uses the cookies necessary for operation and to ensure that we give you the best experience on our website.
By closing this banner, clicking on a link or continuing browsing in any other way, you will agree to use of the cookies. If you want to know more consult the Privacy Policy
Continue